Peter Stalmans.

Peter Stalmans, M.D ., Ph.D., Matthew S. Benz, M.D., Arnd Gandorfer, M.D., Anselm Kampik, M.D., Aniz Girach, M.D., Stephen Pakola, M.D., and Julia A. Haller, M.D. For the MIVI-TRUST Study Group: Enzymatic Vitreolysis with Ocriplasmin for Vitreomacular Traction and Macular Holes The human vitreous body is bounded by the retina and is variably adherent to it posteriorly. Collagen fibrils forming the posterior vitreous cortex are attached at the macula firmly, the central section of the retina where visible acuity is most beneficial, and are connected to its inner limiting membrane through a biochemical glue composed of proteoglycans, including laminin and fibrinectin.1-4 With ageing, the gel-like vitreous progressively liquefies and vitreoretinal adhesions weaken, resulting in separation of the vitreous from the retina, or posterior vitreous detachment.5-7 Vitreomacular adhesion is observed after partial posterior vitreous detachment, when a portion of the posterior vitreous remains mounted on the macula.

7th Annual Individualized & Precision Medicine Conference to be held in Baltimore from Oct. 5 to 6, 2015 Arrowhead's 7th Annual Personalized & Precision Medicine Conference is coming to Baltimore, On October 5-6 MD, 2015 as an official satellite event to the American Culture for Human being Genetics Annual Meeting. This Meeting will be a thrilling possibility to deliberate alongside different stakeholders and experts regarding the ways that healthcare is being reshaped by individualized and precision medicine. This conference brings together multiple stakeholders, including payers, molecular diagnostics companies, genome analysis/interpretation businesses, clinicians and many others in order to offer attendees with a holistic view of the precision medicine landscape.